COMMUNIQUÉS West-GlobeNewswire

RadNet, Inc. to Present at the Barclays High Yield Bond & Syndicated Loan Conference on June 06, 2019
05/06/2019
LOS ANGELES, June 05, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
ReWalk Robotics Announces Exercise of Warrants Resulting in Cash Proceeds of $10.8 Million
05/06/2019
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., June 05, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), today announced the agreement by several accredited investors of its [...]
Triangle Business Journal Recognizes Chiesi USA, Inc. With Third Consecutive Corporate Philanthropy Award
05/06/2019
Chiesi distinguished for its continued service to patients, employees and community partners CARY, N.C., June 05, 2019 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), a specialty pharmaceutical company based in Cary, N.C [...]
Notice of First Quarter Results
05/06/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics Provides Notice of Financial Results for the First Quarter Ended 30 April 2019 Oxford, UK, and Cambridge, MA, US, 5 June 2019 – Summit Therapeutics [...]
“After the Smoke Clears” Brings Hope to Community on the Heels of Mental Health Awareness Month
05/06/2019
Mental health professionals and community leaders lend their time with a mental health event to help people cope with the aftermath of Borderline Bar and Grill Shooting and Woolsey and Hill fires CALABASAS, Calif., June [...]
FOX Business Features Opinion Article Authored by AXIM Biotechnologies, Inc. CEO on Why Legal CBD is Good for Consumers and the Economy
05/06/2019
NEW YORK, June 05, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that it has [...]
CohBar to Hold 2019 Annual Shareholder Meeting and Investor Update June 18, 2019
05/06/2019
MENLO PARK, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) a clinical stage biotechnology company developing mitochondria based therapeutics to treat age-related diseases and extend healthy [...]
Aura Provides Update on Pharmadrug and Its European Strategy
05/06/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, June 05, 2019 ( [...]
Nightstar Therapeutics plc Court Approval Received in Connection With Acquisition by Biogen
05/06/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]
NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield® Designed to Amplify Therapeutic Effect
05/06/2019
Combination of nanoparticle CBD-infused patch/cream and PainShield® intended as powerful alternative to opioids for treatment of pain NanoVibronix partnering with Saralex Group for regulatory approval and global [...]
Flexion Therapeutics Announces Issuance of New U.S. Patent Covering FX201 a Gene Therapy Product Candidate for the Treatment of Osteoarthritis
05/06/2019
BURLINGTON, Mass., June 05, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Patent and Trademark Office (USPTO) has issued patent number 10,301,645 for FX201, the company' [...]
Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million.
05/06/2019
MaxHealth to distribute Biomerica’s colorectal screening test to help identify the early warning signs of colorectal cancer. IRVINE, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced it [...]
Xenon Pharmaceuticals Presents Corporate Update on Neurology-Focused Pipeline at the Jefferies 2019 Healthcare Conference
05/06/2019
Company Highlights Recent Regulatory Feedback Guiding the Clinical Development of XEN901 into Pediatric SCN8A-EE Patients Webcast of Conference Presentation at 11:00 am ET Today BURNABY, British Columbia, June 05, 2019 [...]
Cognition Therapeutics Appoints Anthony O. Caggiano M.D., Ph.D. to the Position of Chief Medical Officer
05/06/2019
Pittsburgh, June 05, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , today announced that Anthony O. Caggiano, M.D., Ph.D. has joined the Company as chief medical officer (CMO). Cognition Therapeutics is a [...]
RTI Surgical® Wins 2019 MedTech Breakthrough Award for TETRAfuse® 3D Technology
05/06/2019
Awards Program Recognizes Outstanding Health and Medical Technology Products and Companies DEERFIELD, Ill., June 05, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company [...]
Engage Therapeutics and Clinical Trial Network of Houston Host New York Times Bestselling Author Kurt Eichenwald for Inspiring Discussion about Overcoming Epilepsy
05/06/2019
Author of “A Mind Unraveled: A Memoir” at Crowne Plaza Houston Near Reliant Medical at 7 p.m. on June 13 HOUSTON, June 05, 2019 (GLOBE NEWSWIRE) -- New York Times bestselling author Kurt Eichenwald will be at Crowne [...]
Quotient Limited to Participate in the Raymond James Life Sciences and MedTech Conference
05/06/2019
JERSEY, Channel Islands, June 05, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Financial Officer, Chris Lindop, will present [...]
Ceapro Presents Positive Results from Avenanthramides Study at the 2019 American Society of Sports Medicine Meeting
05/06/2019
- Data demonstrated that oat avenanthramides supplementation could inhibit molecules involved in the exercise induced inflammation process EDMONTON, Alberta, June 05, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO) (“ [...]
Dermavant Sciences Announces First Patient Dosed in PSOARING, its Pivotal Phase 3 Clinical Program for Tapinarof for the Topical Treatment of Plaque Psoriasis
05/06/2019
Top-line data is anticipated in the first half of 2020 If PSOARING trials are successful, a New Drug Application (NDA) filing with the U.S. Food and Drug Administration (FDA) is anticipated in 2021 BASEL, Switzerland [...]

Pages